Kodiak Sciences Inc KOD Liability Related To Sale Of Future Royalties
Liability Related To Sale Of Future Royalties at other companies
Other financials
Where this comes from
Reported directly by Kodiak Sciences Inc in its filing.
Tagged under the XBRL concept kod:LiabilityRelatedToSaleOfFutureRoyalties.
The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kodiak Sciences Inc's liability related to sale of future royalties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kodiak Sciences Inc's liability related to sale of future royalties?
- Kodiak Sciences Inc (KOD) reported liability related to sale of future royalties of $100M in Q1 2026.
- How has Kodiak Sciences Inc's liability related to sale of future royalties changed year-over-year?
- Kodiak Sciences Inc's liability related to sale of future royalties decreased by 0.0% year-over-year, from $100M to $100M.
- What is the long-term trend for Kodiak Sciences Inc's liability related to sale of future royalties?
- Over 5 years (2020 to 2025), Kodiak Sciences Inc's liability related to sale of future royalties has grown at a 0.0% compound annual growth rate (CAGR), from $99.89M to $100M.
- What does liability related to sale of future royalties mean?
- This represents the financial obligation arising from the upfront monetization of future revenue streams derived from intellectual property or product sales. It reflects a financing arrangement where the company receives immediate capital in exchange for a portion of future royalty payments. Investors monitor this to assess the impact of non-dilutive financing on future cash flows and long-term profitability.